Maxim Norkin
High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer
Norkin, Maxim; Ordóñez-Morán, Paloma; Huelsken, Joerg
Authors
Abstract
Organoids allow the recapitulation of intestinal homeostasis and cancerogenesis in vitro; however, RNA sequencing (RNA-seq)-based methods for drug screens are missing. We develop targeted organoid sequencing (TORNADO-seq), a high-throughput, high-content drug discovery platform that uses targeted RNA-seq to monitor the expression of large gene signatures for the detailed evaluation of cellular phenotypes in organoids. TORNADO-seq is a fast, highly reproducible time- and cost-effective ($5 per sample) method that can probe cell mixtures and their differentiation state in the intestinal system. We apply this method to isolate drugs that enrich for differentiated cell phenotypes and show that these drugs are highly efficacious against cancer compared to wild-type organoids. Furthermore, TORNADO-seq facilitates in-depth insight into the mode of action of these drugs. Our technology can easily be adapted to many other systems and will allow for more systematic, large-scale, and quantitative approaches to study the biology of complex cellular systems.
Citation
Norkin, M., Ordóñez-Morán, P., & Huelsken, J. (2021). High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer. Cell Reports, 35(3), Article 109026. https://doi.org/10.1016/j.celrep.2021.109026
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 31, 2021 |
Online Publication Date | Apr 20, 2021 |
Publication Date | Apr 20, 2021 |
Deposit Date | May 24, 2025 |
Publicly Available Date | May 27, 2025 |
Journal | Cell Reports |
Print ISSN | 2211-1247 |
Electronic ISSN | 2211-1247 |
Publisher | Cell Press |
Peer Reviewed | Peer Reviewed |
Volume | 35 |
Issue | 3 |
Article Number | 109026 |
DOI | https://doi.org/10.1016/j.celrep.2021.109026 |
Keywords | differentiation therapy, colorectal cancer, CRC organoids, high-content screening, organoid screening, drug mode of action |
Public URL | https://nottingham-repository.worktribe.com/output/37604325 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S2211124721003405?via%3Dihub |
Additional Information | This article is maintained by: Elsevier; Article Title: High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer; Journal Title: Cell Reports; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.celrep.2021.109026; Content Type: article; Copyright: © 2021 The Author(s). |
Files
High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer
(6.1 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
You might also like
Biomaterial-based platforms for tumour tissue engineering
(2023)
Journal Article
Designer matrices for intestinal stem cell and organoid culture
(2016)
Journal Article
HOXA5 Counteracts Stem Cell Traits by Inhibiting Wnt Signaling in Colorectal Cancer
(2015)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search